所有图片(1)
About This Item
经验公式（希尔记法）:
C8H8NO5K
CAS号:
分子量:
237.25
EC號碼:
MDL號碼:
分類程式碼代碼:
41116107
PubChem物質ID:
NACRES:
NA.24
推荐产品
等級
analytical standard
品質等級
產品線
VETRANAL®
儲存期限
limited shelf life, expiry date on the label
技術
HPLC: suitable
gas chromatography (GC): suitable
應用
agriculture
clinical
environmental
forensics and toxicology
pharmaceutical (small molecule)
格式
neat
儲存溫度
2-8°C
SMILES 字串
[K+].[H][C@@]12CC(=O)N1[C@@H](C([O-])=O)C(\O2)=C\CO
InChI
1S/C8H9NO5.K/c10-2-1-4-7(8(12)13)9-5(11)3-6(9)14-4;/h1,6-7,10H,2-3H2,(H,12,13);/q;+1/p-1/b4-1-;/t6-,7-;/m1./s1
InChI 密鑰
ABVRVIZBZKUTMK-JSYANWSFSA-M
正在寻找类似产品? 访问 产品对比指南
一般說明
克拉维酸钾是奥沙那南的衍生物，属于β-内酰胺酶抑制剂。它可与青霉素类抗生素联合使用，使它们对β-内酰胺酶产生耐药性。
應用
该分析标准品可用于：
- 利用毛细管电泳（CE）结合电容耦合非接触式电导检测法，对药物制剂中的阿莫西林和克拉维酸钾（C4D）同时进行分析
- 建立一种稳定性指示的高效液相色谱（HPLC）法，并结合质谱（MS）技术，测定阿莫西林、克拉维酸钾及其杂质在其联合剂型中的含量
- 使用紫外分光光度法对克拉维酸钾和阿莫西林三水合物在其原料药、联合片剂制剂和人类尿液样本中进行残留分析
- 利用基于HPLC法的二极管阵列检测器（DAD），在静脉注射的同时测定美罗培南和克拉维酸钾及其降解杂质的含量
- 利用毛细管区带电泳法（CZE），测定联合市售出制剂中阿莫西林和克拉维酸的含量
生化／生理作用
β-内酰胺酶抑制剂，通常加入阿莫西林以提高其功效。
其他說明
有关合适的仪器技术的更多信息，请参阅产品′的检验报告。想要获得更多支持，请联系技术服务部。
法律資訊
VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany
訊號詞
Danger
危險分類
Flam. Sol. 2 - Resp. Sens. 1 - Self-heat. 2 - Skin Sens. 1
安全危害
儲存類別代碼
4.2 - Pyrophoric and self-heating hazardous materials
水污染物質分類（WGK）
WGK 2
閃點（°F）
Not applicable
閃點（°C）
Not applicable
個人防護裝備
Eyeshields, Gloves, type N95 (US)
其他客户在看
Dejenie Shiferaw Teklu et al.
Antimicrobial resistance and infection control, 8, 39-39 (2019-03-01)
The global emergence and spread of extended-spectrum beta-lactamases (ESBLs) producing Enterobacteriaceae have been threatening the ability to treat an infection. Hence, this study aimed to determine the prevalence of ESBL-producing and multi-drug resistance (MDR) Enterobacteriaceae (ESBLs-E) from different clinical specimens
David Baunoch et al.
Infection and drug resistance, 14, 3275-3286 (2021-08-28)
Studies have shown that multiple genes influence antibiotic susceptibility, but the relationship between genotypic and phenotypic antibiotic susceptibility is unclear. We sought to analyze the concordance between the presence of antibiotic resistance (ABR) genes and antibiotic susceptibility results in urine
Yoram Fleissig et al.
Oral surgery, oral medicine, oral pathology and oral radiology, 113(3), e1-e3 (2012-06-09)
A 58-year-old woman presented to the Oral and Maxillofacial Surgery Clinic experiencing severe limited mouth opening and exposed bone in the socket of the right mandibular third molar 8 months following the extraction of the tooth. The patient had been
B R Smith et al.
Drug intelligence & clinical pharmacy, 19(6), 415-420 (1985-06-01)
Potassium clavulanate is a novel beta-lactamase inhibitor, which, in combination, expands the spectrum of amoxicillin to include many amoxicillin-resistant organisms. Potassium clavulanate is excreted 30-50 percent unchanged renally and its plasma time-course parallels that of amoxicillin. Several studies suggest that
Ximena Gonzalo et al.
The Journal of antimicrobial chemotherapy, 68(2), 366-369 (2012-10-17)
To: (i) assess if amoxicillin/clavulanate is a useful option for the management of multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB); (ii) assess if meropenem/clavulanate is active against Mycobacterium tuberculosis at concentrations achievable in vivo; and (iii) determine whether there was inhibition of meropenem/clavulanate
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门